| P50 | author | Burcu Balkan | Q96193250 |
| P2093 | author name string | Aysegul Keser | |
| | Lutfiye Kanit | |
| | Oguz Gozen | |
| | Egemen Kaya | |
| | Ersin O Koylu | |
| | Muzeyyen Ugur | |
| P2860 | cites work | The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system | Q24655164 |
| | Diversity of Dopaminergic Neural Circuits in Response to Drug Exposure | Q28067590 |
| | Analyzing real-time PCR data by the comparative C(T) method | Q28131831 |
| | Common effects of fat, ethanol, and nicotine on enkephalin in discrete areas of the brain | Q28579050 |
| | CRF1-R activation of the dynorphin/kappa opioid system in the mouse basolateral amygdala mediates anxiety-like behavior | Q28580222 |
| | Knockin mice expressing fluorescent delta-opioid receptors uncover G protein-coupled receptor dynamics in vivo | Q30477441 |
| | Suppression of ethanol responding by centrally administered CTOP and naltrindole in AA and Wistar rats | Q31993644 |
| | Nicotinic, glutamatergic and dopaminergic synaptic transmission and plasticity in the mesocorticolimbic system: focus on nicotine effects | Q34450741 |
| | Kappa opioids selectively control dopaminergic neurons projecting to the prefrontal cortex | Q34479813 |
| | Influence of sex and female hormones on nicotine-induced changes in locomotor activity in rats. | Q48286581 |
| | Distribution of dynorphin and enkephalin peptides in the rat brain | Q48321171 |
| | Gene expression of pro-opiomelanocortin and melanocortin receptors is regulated in the hypothalamus and mesocorticolimbic system following nicotine administration | Q48415551 |
| | Repeated administration of cocaine, nicotine and ethanol: effects on preprodynorphin, preprotachykinin A and preproenkephalin mRNA expression in the dorsal and the ventral striatum of the rat. | Q48496306 |
| | Dynorphin-containing pathways in the substantia nigra and ventral tegmentum: a double labeling study using combined immunofluorescence and retrograde tracing | Q48532407 |
| | Distribution of prodynorphin mRNA and its interaction with the NPY system in the mouse brain | Q48672167 |
| | Novel δ1-receptor agonist KNT-127 increases the release of dopamine and L-glutamate in the striatum, nucleus accumbens and median pre-frontal cortex. | Q48698111 |
| | Enkephalin systems in diencephalon and brainstem of the rat | Q48721175 |
| | Nicotine regulates cocaine-amphetamine-Regulated Transcript (Cart) in the mesocorticolimbic system | Q48825613 |
| | Discriminative stimulus properties of nicotine: further evidence for mediation at a cholinergic receptor | Q48830377 |
| | Condition-independent sensitization of locomotor stimulation and mesocortical dopamine release following chronic nicotine treatment in the rat. | Q49018787 |
| | Neuroadaptive effects of active versus passive drug administration in addiction research. | Q35579511 |
| | Nicotinic α4 Receptor-Mediated Cholinergic Influences on Food Intake and Activity Patterns in Hypothalamic Circuits | Q35738540 |
| | The opioid receptors as targets for drug abuse medication | Q35978068 |
| | Stress-induced epigenetic regulation of κ-opioid receptor gene involves transcription factor c-Myc | Q36061430 |
| | Influence of δ-opioid receptors in the behavioral effects of nicotine | Q36174111 |
| | Enkephalin Disinhibits Mu Opioid Receptor-Rich Striatal Patches via Delta Opioid Receptors | Q36423894 |
| | Guidelines on nicotine dose selection for in vivo research. | Q36560437 |
| | [d-Ala2]deltorphin I-like immunoreactivity in the adult rat brain: immunohistochemical localization | Q36603786 |
| | Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway | Q36877274 |
| | Ethanol-induced delta-opioid receptor modulation of glutamate synaptic transmission and conditioned place preference in central amygdala | Q37159944 |
| | Kappa opioid receptors on dopaminergic neurons are necessary for kappa-mediated place aversion | Q37309739 |
| | Nicotinic and opioid receptor regulation of striatal dopamine D2-receptor mediated transmission | Q37439216 |
| | Synergistic activity between the delta-opioid agonist SNC80 and amphetamine occurs via a glutamatergic NMDA-receptor dependent mechanism | Q37675811 |
| | Hypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in ventral tegmental area. | Q37725194 |
| | Cholinergic modulation of dopamine pathways through nicotinic acetylcholine receptors | Q38553717 |
| | Major coexpression of kappa-opioid receptors and the dopamine transporter in nucleus accumbens axonal profiles | Q39750234 |
| | Extrasynaptic neurotransmission in the modulation of brain function. Focus on the striatal neuronal-glial networks. | Q42050477 |
| | Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum | Q42147144 |
| | Functional somato-dendritic alpha7-containing nicotinic acetylcholine receptors in the rat basolateral amygdala complex | Q42500331 |
| | Dopamine signaling in dorsal versus ventral striatum: the dynamic role of cholinergic interneurons. | Q42652289 |
| | Nicotine-induced conditioned place preference in rats: sex differences and the role of mGluR5 receptors | Q43260721 |
| | Nicotine withdrawal and kappa-opioid receptors. | Q43266640 |
| | Chronic nicotine and locomotor activity: influences of exposure dose and test dose | Q43616826 |
| | Different treatment regimens and the development of tolerance to nicotine's anxiogenic effects | Q43722668 |
| | Kappa Opioid Receptor Activation in the Nucleus Accumbens Inhibits Glutamate and GABA Release Through Different Mechanisms | Q43850730 |
| | Anatomical substrates of orexin-dopamine interactions: lateral hypothalamic projections to the ventral tegmental area | Q43975918 |
| | Met-enkephalin and preproenkephalin mRNA changes in the striatum of the nicotine abstinence mouse | Q44002096 |
| | Increased dopamine D3 receptor expression accompanying behavioral sensitization to nicotine in rats. | Q44257885 |
| | κ and δ-opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release | Q44330182 |
| | Kappa-opioid receptor modulation of nicotine-induced behaviour | Q44333473 |
| | Effects of local delta and mu opioid receptor activation on basal and stimulated dopamine release in striatum and nucleus accumbens of rat: An in vivo electrochemical study | Q44334587 |
| | Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study | Q44336066 |
| | Localization of the delta opioid receptor and corticotropin-releasing factor in the amygdalar complex: role in anxiety | Q44338405 |
| | Delta-opioid receptor expression in the ventral tegmental area protects against elevated alcohol consumption. | Q44340810 |
| | The effects of dopamine D1 and D2 receptor antagonists on the rewarding effects of delta 1 and delta 2 opioid receptor agonists in mice | Q44342255 |
| | Effect of the endogenous kappa opioid agonist dynorphin A(1-17) on cocaine-evoked increases in striatal dopamine levels and cocaine-induced place preference in C57BL/6J mice | Q44344098 |
| | Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats | Q44344204 |
| | Desensitization of δ-opioid receptors in nucleus accumbens during nicotine withdrawal | Q44348052 |
| | Nicotine-induced antinociception, rewarding effects, and physical dependence are decreased in mice lacking the preproenkephalin gene. | Q45249966 |
| | Prodynorphin gene disruption increases the sensitivity to nicotine self-administration in mice | Q46307070 |
| | Dynorphin and prodynorphin mRNA changes in the striatum during nicotine withdrawal | Q46686650 |
| | Repeated nicotine exposure modulates prodynorphin and pronociceptin levels in the reward pathway. | Q47411978 |
| | Effect of nicotine use and withdrawal on brain preproenkephalin A mRNA. | Q47798409 |
| P433 | issue | 9 | |
| P921 | main subject | opioid | Q427523 |
| P577 | publication date | 2017-05-16 | |
| P1433 | published in | Synapse | Q7662025 |
| P1476 | title | Chronic nicotine-induced changes in gene expression of delta and kappa-opioid receptors and their endogenous ligands in the mesocorticolimbic system of the rat. | |
| P478 | volume | 71 | |